SmallCap Trading Techniques

[I Like Bottom Fishing]

EAPH CHART PLAY 0.0080 & dd Research work by 'Strukture'

http://www.lamindustries.com/

15-12G / PRE 14A / 10 QSB

http://www.sec.gov/Archives/edgar/data/1071272/000106299305002812/form10qsb.htm

http://www.tickertweets.com/$EAPH-on-twitter.html

http://www.barchart.com/detailedquote/stocks/EAPH

http://finance.yahoo.com/q?s=EAPH&ql=1

http://www.ddmachine.com/default.asp?s=EAPH

http://www.candlestickchart.com/cgi/chart.cgi?symbol=EAPH&exchange=US

http://otcshortreport.com/index.php?index=EAPH

http://www.tickertweets.com/$EAPH-on-twitter.html

http://www.tickertweets.com/$EAPH-on-twitter.html#1week

http://www.tickertweets.com/$EAPH-on-twitter.html#1month

http://www.otcmarkets.com/stock/EAPH/quote

http://www.otcmarkets.com/stock/EAPH/news

http://www.otcmarkets.com/stock/EAPH/financials

http://www.otcmarkets.com/stock/EAPH/filings

http://www.sec.gov/Archives/edgar/data/1071272/000106299305002812/form10qsb.htm

http://www.quotemedia.com/results.php?qm_page=58972&qm_symbol=EAPH

http://www.quotemedia.com/results.php?qm_page=97702&qm_symbol=EAPH

http://www.quotemedia.com/results.php?qm_page=26414&qm_symbol=EAPH

http://www.quotemedia.com/results.php?qm_page=71851&qm_symbol=EAPH

http://www.quotemedia.com/results.php?qm_page=70658&qm_symbol=EAPH

http://www.stockta.com/cgi-bin/analysis.pl?symb=EAPH&cobrand=&mode=stock

http://www.stockwatch.com/Quote/Detail.aspx?symbol=EAPH®ion=U

http://www.barchart.com/cheatsheet.php?sym=EAPH

http://www.sec.gov/Archives/edgar/data/1071272/000106299305002812/form10qsb.htm

http://www.secstates.com/WY_Wyoming_Secretary_of_State_Corporation_Search/

https://wyobiz.wy.gov/Business/FilingSearch.aspx

http://soswy.state.wy.us/Business/BusEntOverview.aspx

https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=246200068020130096088145135249153182130152129003

The Wyoming Secretary of state Business Entity Detail's

ENTITY DETAIL EASTON PHARMACEUTICALS INC.

https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=246200068020130096088145135249153182130152129003

Name: EASTON PHARMACEUTICALS INC. Status: Active
Filing ID: 2012-000626615 Sub Status: Current
Type: Profit Corporation - Domestic Standing - Tax: Good
Old Name: Standing - RA: Good
Fictitious Name: Standing - Other: Good
Sub Type:

Formed in: Wyoming Initial Filing: 07/30/2012
Term of Duration: Perpetual Delayed Effective Date:
Purpose Code: Inactive Date:
Principal Office:
425 University Ave Ste 600
Toronto Ontario M5G1T6
, Canada Mailing Address: 425 University Ave Ste 600
Toronto Ontario M5G1T6
, Canada
ADDITIONAL
DETAILS HISTORY PUBLIC
NOTES PARTIES
ADDITIONAL DETAILS
Registered Agent: 007 Agents, Inc. Agent Address: 1876 Horse Creek Rd
Cheyenne, WY 82009 USA
Latest AR/Year: 01891385 / 2013
AR Exempt: N License Tax Paid: $50.00
Preferred Shares: Preferred Par Value:
Common Shares: 250,000,000 Common Par Value: $0.001

Entity Detail PDF - Print a copy of this Business Entity detail

https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=246200068020130096088145135249153182130152129003

LAM PHARMACEUTICAL CORP CIK#: 0001071272 (see all company filings)

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001071272&owner=exclude&count=40

15-12G / PRE 14A / 10 QSB

http://www.sec.gov/Archives/edgar/data/1071272/000106299305002812/form10qsb.htm

http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH

http://www.barchart.com/cheatsheet.php?sym=EAPH

*DAILY EAPH CHART*

http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH



http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH

http://www.barchart.com/cheatsheet.php?sym=EAPH

*PIVOT POINT EAPH CHART*

http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH



http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/cheatsheet.php?sym=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH

*WEEKLY EAPH CHART*

http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/cheatsheet.php?sym=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH



http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH



http://www.ddmachine.com/default.asp?s=EAPH

http://www.barchart.com/detailedquote/stocks/EAPH

**EAPH dd Research work Filings & News**

EAPH,all in one DD,Could see 30 cents here:
first immense market potential per this:
Aug,23 pr is very primed:

1. "has entered into discussions with 2 private independent companies in Canada for a proposed joint venture or partnership where it would share in any revenues generated in the medical Marijuana industry. Both of the companies currently possess growers licenses within various Provinces in Canada with one of them having affiliations within a clinical marijuana friendly state."

2. Laws currently sitting in other States were expected to have been heard and acted on but were put on hold until sometime later in 2013 or early 2014.

skies the limit here,he medical Marijuana industry could reach nearly $9 billion nationwide in five years, as more states in the United States clear the way to likely legalize marijuana for medicinal purposes

"owned fifteen U.S. patents, nine foreign patents, five U.S. patent applications and
numerous international patent applications designating over 100 foreign countries with claims relating to
our sustained release delivery matrix system, systems containing drug preparations, uses of the systems
for various treatment therapies and addiction therapeutic program. The patents were to expire between
2015 and 2018".

Easton Pharmaceuticals is based in Toronto, Ontario, Canada with a manufacturing partner in a 100,000 sq. ft. FDA approved facility in New Jersey, United States."

NOW READ THIS:

INSIDERS,"CEO & V.P. of AXXESS PHARMACEUTICAL AXXE ($1.00 pps) EACH OWN 10,000,000 RESTRICTED SHARES, THAT IS 20,000,000.. "

Axxess Pharma,Inc.has 34m market cap(52 wk.range:1.03 - 0.74).what's funny, EAPH's fin.even better than AXXE.

ASSETS LIABILITIES RATI0: AXXE(<1) vs EAPH (>1), others fin. Parameter about the same

EAPH's matket cap is only 500k

O/S about 1/3, so equal PPS relating EAPH, is about 30 cents

per those, EAPH PPS should be at least 30 cents,imo (Why at least,Because assets/liabilities ratio even better)

Look what our CFO Neil Mellor did for AXXESS, took them from nothing to $1 PPS.
Now he is working for us at EAPH

NEIL MELLOR - A MUST-READ OF THE CEO-DD IS KING:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91360366

Great fin.

Assets/Liabilities >1 675k/592k.i wish other companies will have so great ratio like EAPH. possitive CASH as well.

only 250m A/S.

EAPH ( 0.0078 ) Is going to be a big runner $$>>

Sun, Sep 01, 2013 at 12:19 AM

From IHub Board Mail

To: email address

This message has been sent by the moderator of the iHub "MOMO'S BREAKOUT BOARD" message board.
http://investorshub.advfn.com/boards/board.aspx?board_id=4929

EAPH (0.0078) is going to be a big runner $$>>

EAPH has some HUGE pending news and a breakout chart ready to explode from its 200 ma $$$

BIG PENDING MJ NEWS and the MJ sector is back inplay now $$$

from Aug,23 pr

1. "has entered into discussions with 2 private independent companies in Canada for a proposed joint venture or partnership where it would share in any revenues generated in the medical Marijuana industry. Both of the companies currently possess growers licenses within various Provinces in Canada with one of them having affiliations within a clinical marijuana friendly state."

2. Laws currently sitting in other States were expected to have been heard and acted on but were put on hold until sometime later in 2013 or early 2014.

skies the limit here,he medical Marijuana industry could reach nearly $9 billion nationwide in five years, as more states in the United States clear the way to likely legalize marijuana for medicinal purposes

"owned fifteen U.S. patents, nine foreign patents, five U.S. patent applications and
numerous international patent applications designating over 100 foreign countries with claims relating to
our sustained release delivery matrix system, systems containing drug preparations, uses of the systems
for various treatment therapies and addiction therapeutic program. The patents were to expire between
2015 and 2018".

Easton Pharmaceuticals is based in Toronto, Ontario, Canada with a manufacturing partner in a 100,000 sq. ft. FDA approved facility in New Jersey, United States."

NOW READ THIS:

INSIDERS,"CEO & V.P. of AXXESS PHARMACEUTICAL AXXE ($1.00 pps) EACH OWN 10,000,000 RESTRICTED SHARES, THAT IS 20,000,000.. "

Axxess Pharma,Inc.has 34m market cap(52 wk.range:1.03 - 0.74).what's funny, EAPH's fin.even better than AXXE.

ASSETS LIABILITIES RATI0: AXXE(<1) vs EAPH (>1), others fin. Parameter about the same

EAPH's matket cap is only 500k

O/S about 1/3, so equal PPS relating EAPH, is about 30 cents

Look what CFO Neil Mellor did for AXXESS, took them from nothing to $1 PPS.
Now he is working at EAPH

NEIL MELLOR - A MUST-READ OF THE CEO-DD IS HUGE:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91360366

Great fin.

Assets/Liabilities >1 675k/592k.i wish other companies will have so great ratio like EAPH. possitive CASH as well.

only 250m A/S.

---------------------------------------------
Replies to this email will be sent directly to the board moderator at [e-mail].

To report abuse forward this email to [e-mail] with your comments.

To unsubscribe from this mail list, click the following link
http://investorshub.advfn.com/boards/DelBoardMailSub.aspx?mem_id=31439&board_id=4929&v=B51D670C650ACC27D636D1D21BD2A28EA7151B0E

*dd Research by: 'Strukture'

NEIL MELLOR - A MUST-READ OF THE CEO-DD IS KING

Biography:

20-year pharmaceutical industry veteran

Neil Mellor is a pharmaceutical executive with over 25 years experience in sales, marketing and business development, both in Canada and Europe. Neil's leadership has driven the successful performance of some of the world's biggest prescription drug brands for companies like GSK-GlazoSmithKline, Pfizer, and Abbott Laboratories.

Neil has extensive experience managing products in the CNS, cardiovascular and GI areas. Some of Neil's greatest success in the market came during his management of Pantoloc (Protonix), which attained sales of +$300m and became the #2 pharmaceutical product in Canada.

In 2009, Neil brought his wide range of understanding and industry acumen to the team at Thought Leader Select http://www.thoughtleaderselect.com/2010/04/29/the-thought-leaders-driving-thought-leader-select-a-blog-series-neil-mellor/ (check the blog), a Chapel Hill, NC-headquartered firm that provides strategy, consulting and research on key opinion leaders and centers of excellence for the biotechnology and pharmaceutical industries.

As business development lead at Thought Leader Select, Neil routinely engages with companies to understand their challenges and strategic needs for better engagement and compliance in their activities with thought leaders in medicine. Neil is passionate about Thought Leader Select's work as a bridge that facilitates collaboration among industry companies and the health care community, insuring that better patient and public health result with each interaction.

Industry Expertise:

1)Biotechnology
2)Pharmaceuticals
3)Health Care - Services
4)Medical Devices
5)Health Care - Providers

http://www.expertfile.com/experts/neil.mellor